Eastman Chemical Company
64.93USD
-0.3800 (-0.58%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on EMN.
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 10.6B | 9.2B | 9.4B | 8.8B | 9.2B | 9.4B |
| Q1 | 2.7B | 2.4B | 2.3B | 2.3B | 2.2B | — |
| Q2 | 2.8B | 2.3B | 2.4B | 2.3B | 2.5B | — |
| Q3 | 2.7B | 2.3B | 2.5B | 2.2B | 2.4B | — |
| Q4 | 2.4B* | 2.2B* | 2.2B* | 2.0B* | 2.2B | — |
Revenue
| (USD) | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
| FY | 6.35 | 7.49 | 7.67 | 4.10 | 6.30 | 6.64 |
| Q1 | 1.80 | 1.12 | 1.39 | 1.57 | .930 | — |
| Q2 | 2.03 | 2.27 | 1.94 | 1.20 | 1.59 | — |
| Q3 | 2.46 | 1.49 | 1.53 | .400 | 1.92 | — |
| Q4 | .008* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| 2.60* |
| 2.80* |
| .908* |
| 1.32 |
| — |
Debt level and coverage